[1] Salcedo M,Pina-Sanchez P,Vallejo-Ruiz V,et al. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security[J]. Asian Pac J Cancer Prev,2014,15(23):10061-10066. [2] 王宇. 我国宫颈癌流行病学特征和发病高危因素的研究进展[J]. 中国妇幼保健, 2019,34(5):1207-1209. [3] Aimagambetova G, Azizan A. Epidemiology of HPV infection and HPV-related cancers in Kazakhstan: a review[J]. Asian Pac J Cancer Prev,2018,19(5):1175-1180. [4] Crow JM. HPV: the global burden[J]. Nature, 2012, 488(7413):S2-S3. [5] Ceccato Junior BP, Guimarães MD, Lopes AP, et al. Incidence of cervical human papillomavirus and cervical intraepithelial neoplasia in women with positive and negative HIV status[J]. Rev Bras Ginecol Obstet,2016,38(5):231-238. [6] Franceschi S, Denny L, Irwin KL, et al. Eurogin 2010 roadmap on cervical cancer prevention[J]. Int J Cancer, 2011,128(12):2765-2674.. [7] Wright TC Jr, Huh WK, Monk BJ, et al. Age considerations when vaccinating against HPV[J]. Gynecol Oncol, 2008,9(2 Suppl):S40-S47. [8] 姜淑清,土送爱,周俊兰.新疆策勒县妇女病现状调查与分析[J].中国妇幼保健,2006,1(4):524-526. [9] Richard C, Lanner C, Naryzhny SN, et al. The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer[J]. Oncogene,2010,29(23):3435-3445. [10] Hang D, Jia M, Ma H, et al. Independent prognostic role of human papillomavirus genotype in cervical cancer[J]. BMC Infect Dis, 2017,17(1):391. [11] 岳钊平, 赵小玲. 女性宫颈疾病患者HPV分型检测结果分析[J]. 海南医学, 2018, 29(13):1836-1838. [12] 徐万洲, 吴青, 李艳, 等. 湖北地区女性人乳头瘤病毒基因分型检测的临床意义[J]. 安徽医药, 2017, 21(6):1030-1033. [13] 张建海, 王前, 王巍,等.北京市大兴区2 117例女性宫颈人乳头瘤病毒感染基因亚型状况分析[J].实用预防医学,2019,26(4):463-470. [14] 赵宇倩, 赵方辉, 胡尚英, 等. 中国女性人群宫颈人乳头瘤病毒感染及型别分布的多中心横断面研究[J]. 中华流行病学杂志, 2015, 36(12):1351-1356. [15] 施卫琴,沈磊芬,蔡丽文.湖州市女性HPV感染及宫颈癌发生情况分析[J].实用预防医学,2021,28(5):621-624. [16] 苏航, 范雪, 艾浩. 不同生育期女性高危型HPV感染调查及相关危险因素分析[J]. 陕西医学杂志, 2021, 50(8):1023-1026. [17] Chen W,Zhang X,Molijn A,et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18[J]. Cancer Causes Control, 2009, 20(9):1705-1713. [18] Maver PJ,Poljak M,Seme K,et al. Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism[J]. J Virol Methods, 2010, 169(1):215-218. [19] 吴宝杰, 杨志建. HPV及其相关疫苗的研究进展[J]. 医学综述, 2018, 24(4):662-666,671. [20] 秦丽欣, 封露露, 刘晓旭,等. 石家庄地区部分女性高危型人乳头瘤病毒感染情况和相关危险因素分析[J]. 中国妇幼保健, 2021, 36(16):3771-3774. [21] 易黎. 妇科门诊妇女HPV感染状况及其影响因素研究[J]. 安徽医药, 2014, 18(4):653-656. [22] 王建彬, 魏然, 梁春梅, 等. 异性恋男性口腔、生殖器人乳头瘤病毒感染及对性伴传播的影响[J]. 实用皮肤病学杂志, 2020, 13(2):92-94,97. [23] 姚岚. 安阳地区女性人乳头瘤病毒感染的流行病学调查[J]. 河南医学研究, 2021, 30(19):3507-3510. [24] 张娟, 苏展影. 中国女性宫颈高危型人乳头瘤病毒感染危险因素的meta分析[J]. 中国临床医生杂志, 2018, 46(12):1482-1486.
2022, Vol. 29 
